MNRGX
Price
$47.50
Change
-$0.98 (-2.02%)
Updated
Nov 13 closing price
Net Assets
19.14M
VTSAX
Price
$160.60
Change
-$2.86 (-1.75%)
Updated
Nov 13 closing price
Net Assets
2.05T
Interact to see
Advertisement

MNRGX vs VTSAX

Header iconMNRGX vs VTSAX Comparison
Open Charts MNRGX vs VTSAXBanner chart's image
Manor Growth
Price$47.50
Change-$0.98 (-2.02%)
VolumeN/A
Net Assets19.14M
Vanguard Total Stock Mkt Idx Adm
Price$160.60
Change-$2.86 (-1.75%)
VolumeN/A
Net Assets2.05T
MNRGX vs VTSAX Comparison Chart in %
View a ticker or compare two or three
VS
MNRGX vs. VTSAX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNRGX is a StrongBuy and VTSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 2.05T vs. MNRGX (19.1M). VTSAX pays higher dividends than MNRGX: VTSAX (1.11) vs MNRGX (0.00). MNRGX was incepted earlier than VTSAX: MNRGX (26 years) vs VTSAX (25 years). MNRGX (0.99) is less costly to investors than VTSAX (0.04). MNRGX is a more actively managed with annual turnover of: 12.05 vs. VTSAX (2.00). MNRGX has a lower initial minimum investment than VTSAX: MNRGX (1000) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 11.52 vs. MNRGX (8.34). VTSAX return over 5 years is better than : 80.80 vs. MNRGX (46.75).
MNRGXVTSAXMNRGX / VTSAX
Total Expense Ratio0.990.042,475%
Annual Report Gross Expense Ratio0.990.042,475%
Fund Existence26 years25 years-
Gain YTD15.59413.952112%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets19.1M2.05T0%
Annual Yield % from dividends0.001.11-
Returns for 1 year8.3411.5272%
Returns for 3 years46.5366.8970%
Returns for 5 years46.7580.8058%
Returns for 10 years144.80225.7164%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RIO71.110.79
+1.12%
Rio Tinto plc
ARWR41.42-0.08
-0.19%
Arrowhead Pharmaceuticals
CEPO10.38-0.02
-0.24%
Cantor Equity Partners I Inc
CRI33.21-0.23
-0.69%
Carter's
QNTM8.33-0.28
-3.31%
Quantum Biopharma Ltd